[Viewpoint] Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality? | ClinicLens
Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ceiling with single agents. This Viewpoint challenges the notion that this ceiling re
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.